Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Cancer. 2012 Jan 26;118(18):4502–4511. doi: 10.1002/cncr.27409

Table 2.

Molecular testing performed on patients

Molecular Cohort

Test(s) Performed ALK+ EGFR+ KRAS+ Triple
Negative
Total
Number
EGFR, KRAS, ALK 32 (78) 29 (74) 27 (55) 80 (100) 168 (80)
EGFR and KRAS only 0 10 (26) 22 (45) 0 32 (15)
EGFR and ALK only 6 (15) 0 0 0 6 (3)
ALK only 3 (7) 0 0 0 3 (1)

Total 41 39 49 80 209